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Abstract 15 
We examined six skeletons from mediaeval contexts from two sites in England for the presence of 16 
Mycobacterium leprae DNA, each of the skeletons displaying osteological indicators of leprosy. 17 
Polymerase chain reactions directed at the species-specific RLEP multicopy sequence produced 18 
positive results with three skeletons, these being among those with the clearest osteological signs of 19 
leprosy. Following in-solution hybridization capture, sufficient sequence reads were obtained to cover 20 
>70% of the M. leprae genomes from these three skeletons, with a mean read depth of 4–10. Two 21 
skeletons from a mediaeval hospital in Chichester, UK, dating to the 14th–17th centuries AD, contained 22 
M. leprae strains of subtype 3I, which has previously been reported in mediaeval England. The third 23 
skeleton, from a churchyard cemetery at Raunds Furnells, UK, dating to the 10th to mid-12th centuries 24 
AD, carried subtype 3K, which has been recorded at 7th–13th century AD sites in Turkey, Hungary and 25 
Denmark, but not previously in Britain. We suggest that travellers to the Holy Land might have been 26 
responsible for the transmission of subtype 3K from southeast Europe to Britain. 27 
 28 
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1. Introduction 31 
 Leprosy is a slowly progressive, chronic granulomatous disease caused by Mycobacterium leprae 32 
(Hansen, 1874) and potentially, in a minority of cases, by the more recently characterised agent 33 
described as Mycobacterium lepromatosis (Han et al., 2008). The primary symptoms are granulomas 34 
of the skin, peripheral nerves and respiratory tract, but sometimes the eyes, skeleton and nasal 35 
cartilage are also affected (Britton and Lockwood, 2004). The bacilli accumulate in the extremities of 36 
the body, invading the Schwann cells causing nerve damage followed by a gradual sensory loss and 37 
eventually leading to deformities and disabilities (Masaki et al., 2013). A multi-drug regime comprising 38 
dapsone, rifampicin and clofazimine has been used successfully to treat 16 million leprosy patients 39 
over the last twenty years, but new infections are frequent with 210,671 leprosy cases reported in 40 
2017 (World Health Organisation, 2018). With the highest incidence of new cases occurring in 41 
northeast South America, central Africa and the Indian subcontinent, leprosy is classified as a 42 
‘neglected tropical disease’ (Lenk et al., 2018). Although the disease itself is curable, leprosy-related 43 
deformities and disabilities are irreversible, especially when treatment has been delayed (Britton and 44 
Lockwood, 2004). Some 2–3 million people worldwide display post-leprosy disfigurements, and many 45 
are subject to the social discrimination referred to as leprosy stigma, which in the past was driven by 46 
misunderstandings regarding transmission of the disease, and which still persists today in some parts 47 
of the world (Grzybowski et al., 2016). 48 
 Leprosy is one of the oldest diseases known to humankind. Although ambiguous, textual 49 
references to skin diseases in the Indian Atharva Veda and Laws of Manu (2000–1500 BC) 50 
(Bloomfield, 2004) and the Egyptian Ebers papyrus (1550 BC) (Hulse, 1972) have been identified as 51 
leprosy, and there are more recent accounts of the disease dating from the 6th century BC to 1st 52 
century AD from India (Bhishagratna, 1996), China (McLeod and Yates, 1981; Leung, 2008), Greece 53 
(Pinhasi et al., 2005) and Rome (Roberts and Manchester, 2010). Additional evidence is provided by 54 
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palaeopathological examination of archaeological skeletons for the osteological manifestations of the 55 
disease that can be observed in the hands, feet, facial bones, tibiae and fibulae of affected skeletons 56 
(Ortner, 2003). The oldest skeleton displaying such lesions dates to 2000 BC, from Rajasthan in 57 
northwest India (Robbins et al., 2009), in accordance with the Indian textual references from the same 58 
period. It has been suggested that the disease was brought to Europe and Northern Africa by the 59 
armies of Alexander the Great, with their return from the Indian campaign in 327–326 C (Roberts and 60 
Manchester, 2010). There is skeletal evidence of leprosy in Egypt at 200 BC (Dzierzykray-Rogalski, 61 
1980) and in Western Europe from the 4th century AD (Reader, 1974). However, the disease appears 62 
to have been uncommon in Europe until the Mediaeval period, when skeletons displaying lesions 63 
become more abundant (Roberts and Manchester, 2010). In Britain, the prevalence of leprosy peaks 64 
in the 13th century AD and then declines during the 15th century AD before becoming uncommon 65 
again from the 16th century AD onwards (for a review of the osteological evidence for Britain, see 66 
Roberts, 2002), possibly because of improved social conditions combined with the development of 67 
enhanced resistance to the disease among the human population (Schuenemann et al., 2013). The 68 
decline is mirrored in continental Europe (Bennike, 2002), although the disease persisted in some 69 
parts of Norway and elsewhere until the 19th century AD (Boldsen, 2001). 70 
 About 5% of leprosy cases develop skeletal changes, and the lesions used in osteological 71 
assessment of the disease can be ambiguous. An important adjunct to palaeopathological analysis 72 
has therefore been provided by the detection and sequencing of M. leprae DNA, which is sometimes 73 
preserved in archaeological skeletons displaying osteological lesions and has also occasionally been 74 
detected in skeletons free from such lesions (Donoghue et al., 2017). Initially, ancient DNA typing was 75 
used mainly to support osteological identifications of leprosy (Rafi et al., 1994; Taylor et al., 2000, 76 
2006; Donoghue et al., 2001, 2005, 2015; Inskip et al., 2015), but with increasing knowledge of 77 
genomic diversity among extant M. leprae strains it has become possible to contextualise ancient 78 
DNA data within an evolutionary scheme for the bacterium (Schuenemann et al., 2018). The M. 79 
leprae genome is 3.27 Mb, substantially smaller than the 4.42 Mb genome of Mycobacterium 80 
tuberculosis, and contains relatively high number of pseudogenes, indicative of reductive evolution 81 
(Singh and Cole, 2011). Different strains show high sequence similarity, with only a small number of 82 
variations in the form of indels (short insertions or deletions) and single nucleotide polymorphisms 83 
(SNPs) (Monot et al., 2009). The SNP variations were initially used to divide modern isolates into four 84 
main types and 16 subtypes called 1A–1D, 2E–2H, 3I–3M and 4N–4P. With the addition of more 85 
sequences, this classification has become elaborated into a phylogenetic scheme comprising six main 86 
branches, with branches 1 and 2 corresponding to types 1 and 2, respectively, branch 3 to subtype 3I, 87 
branch 4 to the type 4 strains and also subtypes 3L and 3M, and branches 5 and 0 to different 88 
variants of subtype 3K (Schuenemann et al., 2013, 2018). Among modern isolates, variants display 89 
geographical partitioning with branch 1 associated with South and East Asia, branch 2 with south and 90 
Southwest Asia, branch 3 with Central and North America, branch 4 with West Africa and South 91 
America, and branches 5 and 0 with East Asia (Monot et al., 2009; Schuenemann et al., 2013). 92 
However, these present-day distributions do not reflect the full complexity of M. leprae distribution in 93 
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the past, especially in mediaeval Europe where subtypes within branches 2, 3, 4 and 0 have been 94 
identified in skeletons dating from the 5th–14th centuries AD (Singh and Cole, 2011). 95 
 Although M. leprae aDNA has been reported from a number of British sites (reviewed by 96 
Donoghue et al., 2017), sufficient data for subtype identification has only been obtained from six 97 
skeletons from the St Mary Magdalen leprosarium in Winchester (Schuenemann et al., 2013; Taylor 98 
et al., 2013; Mendum et al., 2014; Roffey et al., 2017) and one skeleton from a cemetery in Great 99 
Chesterford, Essex (Schuenemann et al., 2018). Three of the Winchester skeletons yielded subtype 100 
3I and the other three, as well as the Great Chesterford sample, were subtype 2F. To extend the 101 
geographical range of our knowledge of ancient M. leprae subtypes in Britain, we carried out a 102 
biomolecular examination of six skeletons from two sites from mediaeval England (Fig. 1), each 103 
displaying pathological lesions indicative of leprosy though with varying degrees of ambiguity. We 104 
report M. leprae genome sequences for three of these skeletons. Two of the genomes correspond to 105 
subtype 3I, previously known in Britain, but the third is novel to Britain and highlights the role that 106 
individual mobility might have played in adding complexity to the phylogeography of M. leprae in 107 
mediaeval Europe. 108 
 109 
 110 
Fig. 1. Locations of the sites from which skeletal samples were obtained. 111 
 112 
2. Material and methods 113 
2.1 Skeletons 114 
 Samples were selected, with permission, from the collection of the Biological Anthropological 115 
Research Centre, University of Bradford, UK, based on various criteria. First, skeletons that clearly 116 
show pathological rhinomaxillary changes indicative of leprosy were identified. Given that these 117 
changes are pathognomonic for lepromatous leprosy, bilateral and symmetrical non-specific changes 118 
in the lower limbs and feet of those skeletons are hypothesized to be associated with the disease as 119 
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well. Additionally, skeletons were sought that showed non-specific lesions in the lower limbs and feet 120 
as commonly seen in leprosy but where no rhinomaxillary alterations could be recorded, either 121 
because they were not present or because they could not be observed due to the state of 122 
preservation of the skeleton. The distribution of these lesions made the differential diagnosis of 123 
leprosy for these skeletons likely. The decision about which skeletal element and, in case of bilateral 124 
skeletal involvement, which side of the body would be sampled, was based on whether or not 125 
destruction was justifiable given the importance of the specimens for future studies.  126 
 Based on these criteria, samples were taken from six skeletons from two sites (Table 1, 127 
Supplementary Note). Skeletons C21, C35, C48 and C227 were excavated in 1989 from a cemetery 128 
that had belonged to the Hospital of St James and St Mary Magdalene, Chichester, UK. The original 129 
hospital was founded c.1118 AD and housed leprosy sufferers until being dissolved in 1442 AD and 130 
converted to an almshouse when the prevalence of leprosy declined in the UK (Magilton et al., 2008). 131 
Based on osteological data, C21 was a young adult male, C35 an adult of indeterminate sex, C48 a 132 
mature adult male, and C227 an adult, probable male. All four skeletons were dated to the 14th–17th 133 
century AD, based on historical documents and associated pottery (Magilton et al., 2008). Skeletons 134 
R5046 and R5256 were males of 17–25 and 25–35 years at age of death, respectively, from the late 135 
Anglo-Saxon churchyard cemetery at Raunds Furnells, Northamptonshire, UK, excavated during 136 
1977–1985. Stratigraphical analyses and radiocarbon dating suggested that the churchyard cemetery 137 
was in use from the mid-10th until mid-12th centuries (Boddington, 1996). 138 
 139 
Table 1 140 
Details of skeletons and samples that were taken. 141 
 142 
Site Skeleton Sex, age at death Leprosy indicatorsa Elements sampleda 








Chichester C21 Young adult male Yes Yes Yes Tibia, metatarsus 
C35 Adult, indeterminate 
sex 
No Yes Yes Tibia 
C48 Mature adult Yes Yes Yes Tibia, fibula 
C227 Male(?) adult Yes Yes Yes Calcaneus, phalanx 
Raunds R5046 Male, 17–25 years Yes Yes Yes Fibula 
R5256 Male 25–35 years No Yes Yes Tibia, fibula, new 
bone formation 
 143 
a For details of lesions and elements sampled, see Supplementary Note (summary of archaeological 144 
sites, pathological lesions of skeletons, and elements that were sampled) and Supplementary Table 1 145 
(detailed osteological report). 146 
 147 
 Skeletons C21, C48 and C227 from Chichester and the Raunds skeleton R5046 displayed 148 
rhinomaxillary changes and other lesions indicative of leprosy (Table 1, Supplementary Note, 149 
Supplementary Table 1). The fourth Chichester skeleton, C35, did not show the typical rhinomaxillary 150 
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changes (the viscerocranium was absent) but had infective destruction of the talonavicular and 151 
tibiotalar joints, an infection of the right calcaneus indicated by the presence of a draining sinus, 152 
dorsal tarsal bars and sub-periosteal new bone formation on the tibiae, fibulae and feet. Individual 153 
R5256 from Raunds also did not show the typical rhinomaxillary changes but had extensive sub-154 
periosteal new bone formation on other skeletal elements. Although initially reported as a case of 155 
possible leprosy (Powell, 1996: 123), this pattern of bone formation is not specific to leprosy, and a 156 
non-leprous diagnosis has been suggested (Craig and Buckberry, 2010). 157 
 158 
2.2 Ancient DNA regime 159 
 DNA extractions, PCRs and Illumina library preparations were performed in two physically 160 
separated laboratories within the specialized ancient DNA research facility at the University of 161 
Manchester. Each laboratory was supplied with ultra-filtered air under positive displacement. After 162 
each use, benches and equipment were decontaminated by UV irradiation and by cleaning with 5% 163 
hypochlorite acid, 70% ethanol and DNA Away (Molecular Bioproducts). Small equipment, plasticware 164 
and UV-stable reagents were decontaminated by UV irradiation (254 nm, 120,000 mJ cm–2 for 2  5 165 
min, with 180° rotation between the two exposures) before use. Aqueous solutions were similarly 166 
irradiated for 15 min. Personnel wore a disposable forensic suit, face mask, hair net, goggles, two 167 
layers of gloves and disposable shoe covers at all times. DNA extractions were accompanied by two 168 
blanks (normal extraction but without skeletal material) per five samples and every set of 5–7 PCRs 169 
was accompanied by at least two blanks (set up with water rather than DNA extract). 170 
 171 
2.3 DNA extraction, PCR and sequencing 172 
 Bone samples were taken using a hacksaw or electronic drill by personnel wearing protective 173 
clothing, including forensic suits, hair nets, face masks and two pairs of sterile gloves. Samples were 174 
placed in sterile plastic bags and stored under dry and cool conditions and transferred to the ancient 175 
DNA facility. The bone surfaces were decontaminated by mechanical removal of the outer 1–2 mm of 176 
each sample, followed by UV irradiation (254 nm, 120,000 mJ cm–2)
 
for 2  5 min, with 180° rotation 177 
between the two exposures (Bouwman et al., 2006). Bone samples were then placed in a DNA-free 178 
plastic bag wrapped in a sterile piece of aluminium foil and crushed into fine powder. DNA was 179 
extracted from 0.2 g of bone powder by standard methods (method D of Bouwman and Brown, 2002; 180 
Dabney et al., 2013). 181 
 An initial screening for presence of M. leprae DNA was carried out by hemi-nested PCR directed 182 
at the RLEP repetitive element, in 50 µl reactions comprising 2.5 µl of DNA extract or 1.0 µl of first 183 
round PCR product, 1 AmpliTaq Gold PCR Master Mix (ThermoFisher Scientific), 2 mM MgCl2, 200 184 
µM dNTPs, 200 ng each primer, 1% bovine serum albumin and 1.25 units AmpliTaq Gold DNA 185 
polymerase (ThermoFisher Scientific). The primers for the first PCR (forward: 5´–186 
CACCTGATGTTATCCCTTGC–3´; reverse: 5´–ATCATCGATGCACTGTTCAC–3) amplified a 133 bp 187 
fragment, and the second PCR (forward: 5´– CATTTCTGCCGCTGGTATC –3´; reverse as for first 188 
PCR) amplified a 111 bp fragment. Cycling conditions were 7 min at 95°C, followed by 35 cycles each 189 
consisting of 1 min at 56°C, 1 min at 72°C, 1 min at 94°C, and a final cycle at 56°C for 1 min and 190 
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72°C for 10 min. PCR products were analysed by agarose gel electrophoresis and directly purified 191 
using the QIAquick PCR product purification kit (Qiagen) prior to Sanger sequencing (GATC Biotech, 192 
Cologne). 193 
 Dual-indexed libraries for Illumina sequencing were prepared from positive samples. No DNA 194 
fragmentation step was performed as ancient DNA is already highly degraded. Library preparation 195 
included a blunt-end repair step but no A-tailing, followed by purification using the MinElute PCR 196 
purification kit (Qiagen), with elution in 20 µl. Subsequent adapter ligation was performed using p5 197 
and p7 adapters at a concentration of 0.2 µM (Meyer and Kircher, 2010). Nicks from the previous step 198 
were filled in with Bst polymerase before quantification by qPCR (Roche LightCycler 480) and 199 
fluorimetry (Qubit 2.0) to determine the number of cycles required for the subsequent indexing PCR. 200 
Sample-specific barcodes were added by double-indexing (Kircher et al., 2012), using KAPA HiFi 201 
Uracil+ (Kapa Biosystems). Samples were then pooled in equimolar ratios and sequenced from both 202 
ends in a single flow cell (Illumina HiSeq 4000). As well as shotgun sequencing, samples were also 203 
sequenced after enrichment by in-solution hybridization capture (MYcroarray) according to the 204 
manufacturer's instructions for degraded samples. RNA baits were transcribed from 80-mer 205 
oligonucleotides complementary to the M. leprae TN genome to give an array with 2 tiling density. 206 
Sequence data are curated at the European Nucleotide Archive under study accession number 207 
PRJEB31393. 208 
 209 
2.4 Data analysis 210 
 Raw sequencing data were pre-processed with AdapterRemoval 2.1 (Schubert et al., 2016) to 211 
remove adapter sequence remnants, trim low quality bases and merge paired-end reads. Reads of at 212 
least 25 bp which formed pairs with at least 11 bp overlap, and non-overlapping pair mates of >25 bp, 213 
were retained in separate files. The paired-end reads were then mapped to the M. leprae TN genome 214 
with BWA 0.7.12 (Li and Durbin, 2009). The alignments were cleaned by soft clipping, sorted based 215 
on coordinate with Picard Tools (http://broadinstitute.github.io/picard), and mapped reads with a 216 
quality score of at least 20 extracted using SAMtools 0.1.19 (Li et al., 2009). Read duplicates were 217 
removed using the MarkDuplicates option in Picard Tools. The mapped reads with duplicates 218 
removed were converted to Fasta files and tested by BLAST (Altschul et al., 1990) with the outputs 219 
visualised using MEGAN 6 (Huson et al., 2016). Base quality score recalibration was performed with 220 
GATK 3.6 (McKenna et al., 2010) using the non-human genome method. The recalibrated alignments 221 
containing the reads that mapped to M. leprae and were verified by BLAST were visualized using 222 
Geneious 8.1.9 (Kearse et al., 2012). Polymorphisms were considered genuine if supported by at 223 
least 5 coverage and a variant frequency of at least 80%. 224 
 225 
3. Results 226 
 Samples (Table 1) were screened for the presence of M. leprae DNA by hemi-nested polymerase 227 
chain reactions (PCRs) directed at the multicopy RLEP element, which is believed to be specific to 228 
this species (Braet et al., 2018) and has previously been used for detection of M. leprae ancient DNA 229 
(Donoghue et al., 2017). The first-round PCRs provided products of the correct size, as judged by 230 
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agarose gel electrophoresis, for the two samples (tibia and metatarsus) taken from skeleton C21, the 231 
two samples (tibia and fibula) from C48, and the single sample (fibula) from R5046 (Table 2). The 232 
second-round PCRs provided bands of the expected sizes from the same samples, and no others. 233 
The results were replicated with a second set of PCRs on the same extracts. None of negative 234 
controls (extraction blanks and PCR blanks) revealed amplification products. Direct sequencing of the 235 
PCR products verified their identity as genuine RLEP amplicons. 236 
 237 
Table 2  238 
Results of RLEP PCRs. 239 
 240 
Skeleton Sampled element PCR resultsa 
C 21 Tibia +,+ 
 Metatarsus +,+ 
C 35 Tibia –,– 
C 48 Tibia +,+ 
 Fibula +,+ 
C227 Calcaneus –,– 
 Phalanx –,– 
R5046 Fibula +,+ 
R5256 Tibia –,– 
 Fibula –,– 
 New bone formation –,– 
 241 
a Result of first hemi-nested PCR, result of second hemi-nested PCR. 242 
 243 
 Samples from the three positive skeletons – C21, C48 and R5046 – were further studied by 244 
Illumina sequencing. Shotgun sequencing was attempted for all three samples but less than 0.001% 245 
of the reads mapped to the M. leprae TN genome, which was insufficient for genome analysis. In-246 
solution hybridization capture was therefore used to enrich the samples for M. leprae sequences. 247 
Enrichment dramatically increased the numbers of reads mapping to the reference genome 248 
(Supplementary Table 2), with >70% of the genome covered for each of the samples and a mean 249 
read depth of 4–10. The data enabled the ancient strains to be assigned to M. leprae genotypes 250 
(Table 3) (Monot et al., 2009), revealing that C21 and C48 belong to subtype 3I and R5046 to subtype 251 
3K. 252 
 253 
Table 3 254 
Genotype assignments. 255 
 256 
Skeleton SNP positiona Type SNP positiona Subtype 
 9 
 14,676 1,642,875 2,935,685  413,902 1,133,492 2,312,059 3,267,975  
C21 C T C 3 G T C G I 
C48 C T C 3 G T C G I 
R5046 C T C 3 G G G G K 
 257 
a SNP positions according to the M. leprae TN genome sequence. 258 
 259 
 Comparisons between different modern strains of M. leprae have revealed a total of 215 260 
polymorphic sites (Monot et al., 2009). These sites were examined in the ancient M. leprae genomes 261 
to determine whether the SNP version that was present was the same as in the M. leprae TN 262 
reference sequence, or was the alternative SNP version present in some other modern genomes 263 
(Supplementary Table 3). Of the three ancient genomes, R5046 was the most greatly diverged from 264 
M. leprae TN, with 119 of the 183 SNPs (65.0%) that were covered by the ancient sequence 265 
displaying the version not present in the reference genome. In comparison, 53.1% and 56.1% of the 266 
SNPs covered in the C21 and C48 genomes, respectively, had the non-reference version. The 267 
greater dissimilarity between R5046 and M. leprae TN reflects the greater phylogenetic distance 268 
between subtype 3K and subtype 1A, to which TN belongs (Schuenemann et al., 2018). An additional 269 
41 sites, comprising 30 SNPs and 11 indels, were specific to the three ancient genomes reported 270 
here (Supplementary Table 4). Of the 30 SNPs, 18 were present only in the R5046 genome, and 271 
seven and five were unique to C21 and C48, respectively. None of the 30 SNPs were present in all 272 
three ancient genomes. Of the eleven indels, five were specific to R5046 and six were present in all 273 
three samples, four of the latter in pseudogenes. 274 
 275 
4. Discussion 276 
 We report the results of analyses of  seven skeletons from two mediaeval sites in England, each 277 
of the skeletons displaying osteological indicators of leprosy, though with different degrees of 278 
ambiguity. We identified M. leprae DNA in three skeletons and following enrichment by in-solution 279 
hybridization obtained sufficient sequence data to assign skeletons C21 and C48 to subtype 3I and 280 
skeleton R5046 to subtype 3K. Although C21 and C48 came from the same cemetery, and were 281 
curated together for 25 years prior to DNA analysis, we can be confident that both contain 282 
endogenous M. leprae DNA (as opposed to cross-contamination between the skeletons or 283 
contamination from a single external source) as their M. leprae genome sequences are non-identical. 284 
 Each of the three skeletons that produced positive results had extensive osteological indications 285 
of leprosy, including rhinomaxillary changes, sub-periosteal new bone formation, and other 286 
characteristic lesions on various skeletal elements. Of the samples that produced negative results, 287 
C227 had a pathological condition most likely indicative of leprosy, in particular pencilling of the fifth 288 
metatarsal with complete resorption of the head and distal part of the diaphysis in the right foot as well 289 
as a slight pitting of the palate. However, this skeleton displayed relatively poor physical preservation, 290 
indicating that the failure to detect M. leprae DNA was possibly due to biomolecular degradation 291 
before the skeleton was excavated. Skeletons C35 and R5256 did not display rhinomaxillary changes, 292 
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weakening the diagnosis of leprosy in both cases. The pathology of the feet of skeleton C35 did 293 
support a diagnosis of leprosy. R5256 had lesions characteristic of leprosy, but displayed new bone 294 
formation on the ossa coxae and left scapula, skeletal elements that are not usually involved in 295 
leprosy infection, possibly suggesting a systemic condition other than leprosy. Overall, the results 296 
confirm those of other groups (Rafi et al., 1994; Taylor et al, 2000, 2006, 2013; Donoghue et al., 297 
2001, 2005, 2015; Inskip et al., 2015) by emphasising the value of ancient DNA analysis as a means 298 
of providing independent support to palaeopathological identifications for leprosy. 299 
 M. leprae strains previously reported from mediaeval Britain and Ireland have been assigned to 300 
subtypes 2F and 3I (Taylor et al., 2013, 2018; Schuenemann et al., 2013, 2018; Mendum et al., 301 
2014), the latter corresponding to branch 3 in the more recent phylogenetic classification 302 
(Schuenemann et al., 2018). The discovery of subtype 3I in two skeletons from Chichester, dating to 303 
the 14th–18th centuries AD, is therefore consistent with the results of these previous studies. Subtype 304 
3K, however, has not previously been reported in Britain. In modern M. leprae, this subtype is 305 
associated with East Asia, in particular Japan, China, the Philippines and New Caledonia 306 
(Schuenemann et al., 2018). Among ancient specimens it has been detected in a Turkish skeleton 307 
from the 8th–9th centuries AD (Erdal, 2004), three skeletons from Hungary, from the 7th–10th centuries 308 
AD (Pálfi et al., 2002; Molnár et al., 2006; Schuenemann et al., 2018), and another from 11th–13th 309 
century AD Denmark (Schuenemann et al., 2018). The R5046 skeleton is from a similar period (10th 310 
to mid-12th centuries AD) as are these other European detections, but is the most westerly in location, 311 
and hence the most distant from the modern distribution of the subtype. The distribution pattern raises 312 
the intriguing possibility that the individual represented by skeleton R5046 did not contract leprosy in 313 
Britain but instead had travelled to continental Europe and/or Asia and contracted the disease there. It 314 
has previously been suggested that human mobility along the Silk Route was responsible for bringing 315 
subtype 3K to Eastern Europe from its supposed centre of origin in East Asia (Monot et al., 2009). 316 
During the Anglo-Saxon period, up until the 10th century AD, there was also extensive travel between 317 
Britain and continental Europe, especially of educated clerics who taught and held religious positions 318 
in various European countries (Palmer, 2009). One of the routes taken by travellers to reach the Holy 319 
Land from West and Central Europe began in Vienna and passed along the Danube and the Via 320 
Diagonalis to Constantinople, traversing Hungary, Serbia and Bulgaria (The Way to Jerusalem, 2018). 321 
It is therefore possible that leprosy of subtype 3K was transmitted to Britain and other parts of 322 
Western Europe by people who had travelled to the Holy Land and back via this route. 323 
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